MedPath

The Effects of Neoadjuvant Chemotherapy for Colorectal Liver Metastases on Functional Hepatic Reserves as Assessed by Indocyanine Green Clearance - A Pilot Study.

Recruiting
Conditions
Colorectal Liver Metastases
Cancer - Liver
Cancer - Bowel - Back passage (rectum) or large bowel (colon)
Registration Number
ACTRN12606000354583
Lead Sponsor
Professor Guy J Maddern
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Written, informed consent to participate in trial.·Patients undergoing neoadjuvant chemotherapy for resectable/unresectable colorectal metastases or, ·Patients undergoing liver resection for resectable colorectal metastases. ·Patients who have either never had chemotherapy or who have undergone chemotherapy previously (excluding 12 months prior to enrolment in this trial).

Exclusion Criteria

Patients who are pregnant or who are breast-feeding. It is unknown if ICG can cause harm to a foetus or baby.·A history of allergy to iodides as ICG contains sodium iodide and should be used with caution. ·Patients whom the investigator does not see fit to be involved in this study. ·Patients who have undergone chemotherapy in the last 12 months.·Patients who are unable to give informed consent.Precautions·Radioactive iodine uptake studies should not be performed for at least a week following the use of ICG.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the optimal time for liver regeneration and liver resection in patients who have undergone neoadjuvant chemotherapy for colorectal liver metastases, as assessed by Indocyanine Green Clearance dye.[ The outcome will be assessed after 10 patients to ascertain if the trial is producing any results (given that it is a pilot study).]
Secondary Outcome Measures
NameTimeMethod
To investigate the potential correlation of changes over time from neoadjuvant chemotherapy in parenchyma function using Indocyanine Green Clearance dye.[The outcome will be assessed after 10 patients to ascertain if the trial is producing any results (given that it is a pilot study).]
© Copyright 2025. All Rights Reserved by MedPath